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Abstract 
We investigated whether lipid extract from a blue-green alga, N. commune, modulates proinflamma-
tory gene expression in RAW 264.7 macrophages. The cells were incubated with N. commune lipid 
extract (0–100 μg/mL) and subsequently activated by LPS (100 ng/mL). Quantitative real-time PCR 
analysis showed that mRNA abundance of proinflammatory mediators, including TNF-α, COX-2, 
IL-1β, IL-6, and iNOS, was significantly reduced by N. commune lipid extract in a dose-dependent 
manner. Secretion of TNF-α and IL-1β into cell culture medium was also significantly decreased by 
N. commune lipid extract. Thin-layer chromatography-densitometry analysis showed that N. com-
mune lipid extract contained approximately 15% of fatty acids. To determine whether the inhibition 
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of proinflammatory mediator production by N. commune lipid extract is primarily conferred by fatty 
acids in the lipid extract, macrophages were incubated with 100 μg/mL of N. commune lipid extract 
or 15 μg/mL of a fatty acid mixture, which was formulated to reflect the fatty acid composition of N. 
commune lipid extract. The fatty acid mixture significantly reduced RNA abundance of TNF-α and 
COX-2, but to a lesser extent than did the N. commune lipid extract, suggesting the presence of addi-
tional bioactive compounds with an anti-inflammatory property in the lipid extract. As NF-κB is a 
major regulator for the proinflammatory gene expression, we measured its DNA-binding activity. 
DNA-binding activity of NF-κB was significantly reduced by N. commune lipid extract. In conclusion, 
our study suggests that N. commune lipid extract represses the expression of proinflammatory genes 
in RAW 264.7 macrophages, at least in part, by inhibiting the activation of NF-κB pathway. 
 
Keywords: blue-green algae, Nostoc commune var sphaeroides, anti-inflammatory, NF-κB, RAW 264.7 
macrophages 
 
Abbreviations: COX-2, cyclo-oxygenase 2; iNOS, inducible nitric oxide synthase; IL-1β, interleukin-
1β; IL-6, interleukin-6, LPS, lipopolysaccharide; NF-κB, nuclear factor-kappa B; N. commune, Nostoc 
commune var sphaeroides Kützing; TNF-α, tumor necrosis factor-α 
 
1. Introduction 
 
Chronic inflammation can result in an elevated risk of various chronic inflammatory dis-
eases such as atherosclerosis, rheumatoid arthritis, chronic obstructive pulmonary disease, 
asthma, and inflammatory bowel disease. Pharmaceutical anti-inflammatory drugs are 
generally used to treat these diseases. In general, the anti-inflammatory drugs reduce in-
flammatory response by suppressing the production of proinflammatory mediators, such 
as tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β), and nitric oxide, which are in-
volved in the pathogenesis of inflammatory diseases [1,2]. However, reports on the in-
creased risk of cardiovascular disease with long-term use of several nonsteroidal anti-
inflammatory drugs have raised concerns over using the drugs [3]. In addition, increasing 
the public’s preference for natural and herbal medicines to drug therapies in preventing 
and treating chronic inflammatory diseases has prompted the discovery and development 
of new bioactive natural products with anti-inflammatory properties. 
Blue-green algae, also termed cyanobacteria, are among the most primitive forms of life 
on Earth [4]. Bioactive compounds isolated from blue-green algae have been shown to be 
neuroprotective, cytotoxic, antibacterial, antifungal, antiviral, and anti-inflammatory [5–9]. 
Edible blue-green algae, such as Spirulina and Aphanizomenon flos-aquae, are currently mar-
keted as dietary supplements with various health claims for immune function, inflamma-
tion, heart disease, and general well-being. Concerns over naturally grown blue-green 
algae, however, have been raised because of contamination from algal toxins and heavy 
metals. During the harvesting of natural blue-green algae, they are easily contaminated 
with toxin-producing algae such as Microcystis aeruginosa, which generates microcystins, 
potent hepatotoxins [10]. In addition, the quality of naturally grown blue-green algae can 
vary depending on the growth environments; for example, altitude, temperature, and sun 
exposure [11]. 
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To develop a new natural source with health-enhancing properties, an edible blue-green 
alga, Nostoc commune var sphaeroides Kützing (N. commune), was cultivated. N. commune has 
been used as a food delicacy or herbal medicine in Asian, African, and South American 
countries for centuries [12]. N. commune has been used as an ingredient of Chinese medi-
cine since the Eastern Jin Dynasty (317–420 AD) as recorded in The Supplement to Compen-
dium of Materia Medica [13]. It has been historically suggested that N. commune can treat a 
variety of medical conditions, including inflammation, night blindness, digestion, burns, 
anxiety, indigestion, and chronic fatigue. In addition, a hypocholesterolemic effect of N. 
commune was suggested in rats fed N. commune, which was attributed to its high content of 
dietary fibers [14]. Although studies have also demonstrated various health benefits from 
N. commune, including cholesterol lowering, antiviral, anticancer, and anti-inflammatory 
activities [8,14–19], a mechanistic investigation on the biological functions of N. commune 
is very limited. 
In the present study, we intended to elucidate the molecular mechanisms responsible 
for an anti-inflammatory function of cultivated N. commune, which is free of contamination 
of toxins and whose quality can be controlled by culture conditions. Our hypothesis was 
that lipid extract of N. commune exerts an anti-inflammatory property by repressing the 
expression of proinflammatory genes through the inhibition of nuclear factor-κB (NF-κB), 
a major transcription factor for proinflammatory response. As macrophages play an im-
portant role in the innate immune system, we performed our experiments using murine 
RAW 264.7 macrophages, as the macrophages are widely used as an in vitro model for 
studies on inflammatory pathways. Our data indicate that lipid extract of N. commune 
reduced the production of proinflammatory mediators, such as TNF-α, IL-1β, cyclooxy-
genase 2 (COX-2), inducible nitric oxide synthase (iNOS), and IL-6. This repression is me-
diated, at least in part, by inhibiting the activation of NF-κB. Our study provides, for the 
first time, scientific support for N. commune to be developed as a nutritional food to reduce 
the risk of inflammatory diseases. 
 
2. Methods and materials 
 
2.1. Preparation of N. commune lipid extract 
Fresh N. commune was obtained from Algaen Corporation (Winston Salem, North Caro-
lina). N. commune was freeze-dried and ground for lipid extraction using the Bligh-Dyer 
method [20]. Briefly, 42 mL of chloroform/methanol (1:2 vol/vol) was added to approxi-
mately 3 g of dry N. commune and vortexed. After the addition of 14 mL of chloroform and 
10.6 mL of distilled water, the sample was mixed and filtered using a Whatman filter no. 
42 (Whatman, Inc., Ann Arbor, Michigan) to remove solids. Subsequently, 6.3 mL of 0.05% 
H2SO4 was added, and samples were vortexed. To separate phases, samples were centri-
fuged at 500 × g for 5 minutes and the lower liquid phase was recovered. Lower phase was 
dried to completion under nitrogen, weighed for lipid mass, and resuspended in chloro-
form. Tubes containing lipid extract were purged with nitrogen and tightly sealed. The 
lipid extract was stored at −80°C with an oxygen absorber Ageless (Mitsubishi Gas Chem-
ical America, New York, New York) to prevent oxidation until use. To incorporate the lipid 
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extract into cell culture medium, chloroform was evaporated under nitrogen, and medium 
was added for subsequent sonication at room temperature for 5 minutes. 
 
2.2. Compositional analysis of N. commune lipid extract 
The simple lipids of N. commune lipid extract were determined by thin-layer chromatography 
(TLC)–densitometry using a solvent system of hexane/diethyl ester/acetic acid (85:15:2 by 
volume) as previously described [21]. Images of the plates were obtained with a Kodak Gel 
Logic 440 imaging system and Kodak ID image analysis software (Kodak, Rochester, New 
York), and the sample spots were compared against external standards for migration and 
net band intensity. 
Fatty acid composition of N. commune lipid extract was determined by gas chromatog-
raphy. An aliquot of N. commune lipid extract (2 mg in chloroform) was dried under nitro-
gen. Fatty acid methyl esters were prepared by the method of Metcalfe et al [22] and 
quantified using a 0.25 mm × 100 m CP-Sil-88 capillary column (Chrompack, Raritan, New 
Jersey) under the following conditions: initial temperature, 180°C for 20 minutes, increased 
to 250°C at 5°C/min; injector temperature, 270°C; flame ionization detector temperature, 
300°C; helium carrier gas; and split ratio of 50:1. 
The carotenoid content of lipid extract was determined by high-performance liquid 
chromatography as previously described [23]. 
 
2.3. Cell culture and treatment 
Murine RAW 264.7 macrophages (ATCC no. TIB-71) were maintained in RPMI 1640 con-
taining 10% FBS, 100 U/mL of penicillin, 100 μg/mL of streptomycin, 2 × vitamins (from 
100 × vitamin solution, MediaTech, Herndon, Virginia), and 2 mmol/L L-glutamine in a 
humidified chamber at 37°C with 5% carbon dioxide. All cell culture supplies were pur-
chased from MediaTech. 
Cells were plated at a density of 6 × 105 μg cells in a well of 12-well plates. When cells 
became approximately 90% confluent, increasing concentrations of N. commune lipid ex-
tract (0–100 μg/mL) were added to culture medium for 12 hours, after which 100 ng/mL of 
lipopolysaccharide (LPS) (Salmonella enterica serotype typhimurium; Sigma-Aldrich, St. 
Louis, Missouri) was added to the cell medium to activate cells for 18 hours. In separate 
experiments, cells were incubated with either N. commune lipid extract (100 μg/mL) or a 
fatty acid mixture (15 μg/mL), consisting of 26% palmitic acid, 24% palmitoleic acid, 7% 
oleic acid, 16% linoleic acid, and 25% linolenic acid, for 12 hours. After the incubation, LPS 
(100 ng/mL) was added to activate macrophages for 18 hours. Fatty acids were complexed 
with bovine serum albumin (BSA, approximate molar ratio of BSA/fatty acid = 1:2.5), and 
therefore, the same amount of BSA was added to all the treatments. For all cell culture 
experiments, cells that were not incubated with N. commune lipid extract served as a con-
trol. 
 
2.4. Cytotoxicity measurement 
Cytotoxicity of N. commune lipid extract was determined using In Cytotox crystal violet 
dye elution (CVDE) kit (Aniara, Mason, Ohio) according to the manufacturer’s instruc-
tions. In brief, RAW 264.7 macrophages were plated at a density of 25,000 cells per well in 
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a 96-well plate and incubated for 24 hours, after which 0 to 200 μg/mL of N. commune lipid 
extract was added for 24 hours. Cells were washed twice with 200 μL per well of wash 
solution CVDE I and 100 μL of labeling solution CVDE II was added to each well. After 
incubation for 10 minutes at room temperature, the cells were washed 4 times with dis-
tilled water. The plate was air dried, and the cell layer was dissolved with 100 μL per well 
of solubilization solution CVDE III. The absorbance was measured at 540 nm. Sodium do-
decyl sulfate (SDS; 0.5 mmol/L) was used as a positive control for cytotoxicity. Data are 
expressed as viability (%) relative to control that was not incubated with N. commune lipid 
extract. 
 
2.5. Total RNA isolation and quantitative real-time PCR 
Cells were washed twice with cold phosphate buffered saline (PBS) and 1 mL of Trizol 
reagent (Invitrogen, Carlsbad, California) was added to each well of a 12-well plate to iso-
late total RNA following the manufacturer’s protocol. One microgram of total RNA was 
treated with DNase I (Promega, Madison, Wisconsin) to remove genomic DNA contami-
nation, and subsequently, RNA samples were reverse transcribed by MMLV reverse tran-
scriptase (Promega, Madison, Wisconsin). Realtime PCR analysis was performed using the 
Sybr Green procedure and an ABI 7300 instrument (Applied Biosystems, Foster City, Cal-
ifornia). Primers for TNF-α, COX-2, IL-1β, IL-6, iNOS, and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) were designed according to GenBank database using the Primer 
Express 3.0 software provided by ABI and listed in Table 1. Expression of mRNA values 
was calculated using the threshold cycle (Ct) value, that is, the number of PCR cycles at 
which the fluorescent signal during the PCR reaches a fixed threshold. For each sample, 
ΔCt, sample was calculated by subtracting the Ct value of GAPDH, a housekeeping gene, from 
that of each gene of interest to normalize the data. The expression levels relative to control 
were estimated by calculating ΔΔCt(ΔCt, sample – ΔCt, control) and subsequently using the 2−ΔΔCt 
method [24]. 
 
Table 1. Real-time PCR primers 
Gene Forward primer Reverse primer 
TNF-α 5′-GGCTGCCCCGACTACGT-3′ 5′-ACTTTCTCCTGGTATGAGATAGCAAAT-3′ 
IL-1β 5′-GTCACAAGAAACCATGGCACAT-3′ 5′-GCCCATCAGAGGCAAGGA-3′ 
COX-2 5′-AAAGGTTCTTCTACGGAGAGAGTTCA-3′ 5′-TGGGCAAAGAATGCAAACATC-3′ 
IL-6 5′-CTGCAAGAGACTTCCATCCAGTT-3′ 5′-AGGGAAGGCCGTGGTTGT-3′ 
iNOS 5′-GCAGCTGGGCTGTACAAA-3′ 5′-AGCGTTTCGGGATCTGAAT-3′ 
GAPDH 5′-TGTGTCCGTCGTGGATCTGA-3′ 5′-CCTGCTTCACCACCTTCTTGAT-3′ 
 
2.6. Enzyme-linked immunosorbent assay for cytokines 
Concentrations of TNF-α and IL-1β in cell medium were determined by commercial mouse 
enzyme-linked immunosorbent assay (ELISA) kits (eBiosciences, San Diego, California) 
following the manufacturer’s protocols. 
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2.7. Nuclear extract preparation and NF-κB activity measurement 
RAW 264.7 macrophages were incubated without or with N. commune lipid extract (100 
μg/mL) followed by activation with 100 ng/mL of LPS for 1 hour. Cells were then washed 
twice with cold PBS, and nuclear fraction was prepared using Nuclear Extract kit (Active 
Motif, Carlsbad, California) following the manufacturer’s instruction. Protein concentra-
tions of samples were measured by BCA assay (Pierce, Rockford, Illinois) using BSA as a 
standard. 
DNA-binding activity of p65 was assessed using an ELISA-based TransAM NF-κB p65 
assay kit (Active Motif). Briefly, 20 μL of complete lysis buffer containing 3 μg of nuclear 
extract was added to a well of a 96-well plate coated with immobilized NF-κB consensus 
oligonucleotides and incubated for 1 hour with slow agitation. Primary NF-κB antibody 
was added and incubated for 1 hour, after which wells were washed 3 times with a wash-
ing buffer. Horseradish peroxidase-conjugated secondary antibody was added, and after 
1-hour incubation, wells were washed 4 times with a washing buffer. Color was developed 
and optical density was measured by a spectrophotometer (Bio-Tek, Winooski, Vermont) 
at 450 nm with a reference wavelength of 655 nm. Positive and negative controls were run 
simultaneously to validate the assay. 
 
2.8. Statistical analysis 
Treatment effects were analyzed by one-way analysis of variance (one-way ANOVA), and 
statistically significant differences among treatments were identified using Tukey’s pair-
wise comparison using GraphPad InStat 3 (GraphPad Software, Inc., San Diego, Califor-
nia). Differences were considered significant at P < .05. Data are expressed as means ± SEM. 
 
3. Results 
 
3.1. Lipid composition of N. commune lipid extract 
Extractable lipid compounds present in N. commune were determined by TLC-densitometry. 
The lipid extract contained pigments, free fatty acids, triacylglycerol, vitamin E, and wax 
esters/steryl esters (Fig. 1). Although a large percentage of pigments were observed in this 
lipid extract, identification of the pigments was beyond the scope of this study. The fatty 
acid composition of lipid extract was approximately 26% palmitic acid (16:0), 24% pal-
mitoleic acid (16:1), 16% linoleic acid (18:2), and 25% linolenic acid (18:3) (Table 2). Assum-
ing that carotenoids contributed to the high level of pigmentation in the lipid extract, we 
attempted to quantify several carotenoids, including α-carotene, β-carotene, lutein, lyco-
pene, cryptoxanthin, and zeaxanthin. Only β-carotene was detected with a concentration 
of 70 mg/100 g dry weight. 
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Figure 1. Lipid analysis of N. commune lipid extract by TLC-densitometry. Lipids of 
N. commune and lipid standards were fractionated on a silica gel plate and developed using 
hexane-diethyl ether-acetic acid (85:15:2, by volume). Bands were visualized by submerg-
ing the plate in a solution of 10% cupric sulfate and 8% phosphoric acid and subsequently 
by charring the dried plate at 165°C for 10 minutes. The TLC standard for lipids is shown 
in the right. 
 
Table 2. Fatty acid composition of N. commune lipid extracta 
Fatty acid % of total fatty acids 
14:0 0.62 ± 0.02 
16:0 25.7 ± 0.38 
16:1 Δ9 24.1 ± 0.40 
18:0 2.2 ± 0.23 
18:1 Δ9 4.3 ± 0.16 
18:1 Δ11 2.2 ± 0.03 
18:2 15.6 ± 0.18 
18:3 25.3 ± 0.18 
Values are mean ± SEM (n = 6). 
a. Fatty acid composition of N. commune lipid extract was deter-
mined by GC analysis. 
 
3.2. Cytotoxicity of N. commune lipid extract in RAW 264.7 macrophages 
Cytotoxicity of N. commune lipid extract was assessed by incubating RAW 264.7 macro-
phages with increasing concentrations (0–200 μg/mL) of the lipid extract for 24 hours. Cells 
incubated with 25 to 200 μg/mL of N. commune lipid extract showed a comparable viability 
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with control (Fig. 2). This result indicates that N. commune lipid extract is not cytotoxic to 
RAW 264.7 macrophages within this range. 
 
 
 
Figure 2. Cytotoxicity of N. commune lipid extract. RAW 264.7 macrophages were incu-
bated with 0 to 200 μg/mL of N. commune lipid extract or 0.5 mmol/L SDS as a positive 
control for cytotoxicity for 24 hours. Cell viability was determined using In Cytotox crys-
tal violet dye elution kit. Data are expressed as viability (%) relative to control that was 
not incubated with N. commune lipid extract. Bars without a common letter are signifi-
cantly different (P < .05) using one-way ANOVA and Tukey’s pairwise comparison. Val-
ues are means ± SEM (n = 4–5). 
 
3.3. Repression of the expression of proinflammatory mediators by N. commune lipid extract 
Despite that health benefits from N. commune have been recognized in Chinese medicine, 
there are very few studies in the scientific literature that have addressed this issue. To in-
vestigate whether lipid extract from N. commune could decrease the expression of proin-
flammatory mediators in RAW 264.7 macrophages, we incubated the cells with increasing 
concentrations of N. commune lipid extract (0–100 μg/mL) for 12 hours. Subsequently, the 
cells were activated with LPS (100 ng/mL), a component of gram-negative bacterial cell 
wall, for an additional 18 hours. N. commune lipid extract reduced mRNA abundance of 
proinflammatory mediators, including TNF-α, COX-2, IL-1β, IL-6, and iNOS, in a dose-
dependent manner (Fig. 3A). Consistent with mRNA levels, secretion of TNF-α and IL-1β 
into culture medium was also significantly reduced by N. commune lipid extract (Fig. 3B). 
N. commune lipid extract appears to contain bioactive compounds that can antagonize the 
production of LPS-induced proinflammatory mediators. 
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Figure 3. N. commune lipid extract inhibited the production of proinflammatory mediators 
in LPS-activated RAW 264.7 macrophages. Cells were incubated with increasing concen-
trations of N. commune lipid extract (0–100 μg/mL) for 12 hours, and LPS (100 ng/mL) was 
added to activate macrophages for 18 hours. (A) Real-time PCR analysis for mRNA ex-
pression of proinflammatory genes. Data are expressed as fold change relative to control 
treated with LPS. Bars without a common letter are significantly different (P < .05). Values 
are means ± SEM (n = 4–5). (B) Cytokine concentrations. TNF-α and IL-1β concentrations 
in the medium collected after the incubation with N. commune lipid extract and LPS were 
determined by ELISA. Data without a common letter are significantly different (P < .05) 
using one-way ANOVA and Tukey’s pairwise comparison. Values are means ± SEM (n = 6). 
 
3.4. Effect of fatty acid mixture on the expression of proinflammatory mediators 
Palmitoleic acid, linoleic acid, and linolenic acid, which consist of approximately 75% of 
total fatty acids in N. commune lipid extract, inhibited the expression of proinflammatory 
genes in RAW 264.7 macrophages, whereas palmitic acid increased the expression of those 
genes (unpublished data). To address whether the unsaturated fatty acids in N. commune 
lipid extract play a major role in the reduced production of proinflammatory mediators by 
N. commune, we formulated a fatty acid mixture that reflects the same fatty acid composi-
tion of N. commune lipid extract. TLC-densitometry analysis showed that the N. commune 
lipid extract contains approximately 15% fatty acids (Fig. 1). Therefore, we incubated RAW 
264.7 macrophages with N. commune lipid extract (100 μg/mL) or 15 μg/mL of a fatty acid 
mixture, which contains the same amount and composition of fatty acids as 100 μg/mL of 
the lipid extract, for 12 hours. Subsequently, the cells were activated by LPS for 18 hours. 
LPS drastically induced mRNA expression of TNF-α and COX-2 in control groups, whereas 
N. commune lipid extract inhibited the induction of TNF-α and COX-2 expression (Fig. 4). 
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Although the addition of 15% of fatty acid mixture significantly reduced the mRNA abun-
dance of both genes compared with LPS-treated control, the degree of repression was less 
than that of N. commune lipid extract. The data suggest that in addition to unsaturated fatty 
acids, other bioactive compounds with an anti-inflammatory role are present in N. com-
mune lipid extract that may inhibit the production of proinflammatory mediators in RAW 
264.7 macrophages. 
 
 
 
Figure 4. N. commune lipid extract contains bioactive compounds with an anti-inflammatory 
property. RAW 264.7 macrophages were incubated with N. commune lipid extract (100 
μg/mL) or fatty acid mixture (15 μg/mL) for 12 hours, after which cells were activated by 
LPS (100 ng/mL) for 18 hours. Real-time PCR analysis was performed to measure mRNA 
abundance of TNF-α and COX-2. Data are a representative of 2 separate experiments and 
expressed as fold change relative to control without LPS treatment. Bars without a com-
mon letter are significantly different (P < .05) using one-way ANOVA and Tukey’s pair-
wise comparison. Values are means ± SEM (n = 3). 
 
3.5. Inhibition of NF-κB p65 DNA binding activity by N. commune lipid extract 
To address whether N. commune lipid extract inhibits the production of proinflammatory 
mediators by blocking the NF-κB signaling pathway, we measured p65 DNA-binding ac-
tivity in RAW 264.7 macrophages after the incubation with 100 μg/mL of N. commune lipid 
extract. Control experiments were run simultaneously for validity of assay using a positive 
control and wild-type and mutant oligos provided by the manufacturer (data not shown). 
In the absence of N. commune lipid extract, LPS significantly increased p65 DNA binding 
activity (Fig. 5). However, the addition of N. commune lipid extract inhibited LPS-induced 
NF-κB activation, indicating that the anti-inflammatory role of N. commune lipid extract is 
mediated, at least in part, through its inhibition of NF-κB activation. 
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Figure 5. NF-κB p65 DNA-binding activity was inhibited by N. commune lipid extract. 
RAW 264.7 macrophages were incubated with 0 or 100 μg/mL of N. commune lipid extract 
for 12 hours, after which they were activated by LPS (100 ng/mL) for 1 hour. Nuclear 
extract was prepared, and p65 DNA-binding activity was measured using TransAM NF-κB 
p65 assay kit. Data are expressed as activity relative to control without LPS. Bars without 
a common letter are significantly different (P < .001) using one-way ANOVA and Tukey’s 
pairwise comparison. Values are means ± SEM (n = 6). 
 
4. Discussion 
 
In this study, we investigated whether N. commune exerts an anti-inflammatory function 
and, if so, the mechanisms of action underlying such a function. We used cultivated N. 
commune, which is free of contamination of toxins and heavy metals and is under tight 
quality control during culture. Lipid extract from cultivated N. commune reduced the pro-
duction of proinflammatory mediators by inhibiting, at least in part, the activation of NF-κB 
pathway in RAW 264.7 macrophages. 
N. commune lipid extract contains pigments, free fatty acids, triacylglycerol, vitamins, and 
wax and steryl esters as demonstrated by TLC-densitometry analysis. Fatty acids have been 
implicated in modulating inflammatory responses [25] and they comprise approximately 
15% of the total N. commune lipid extract. In addition, as approximately 75% of fatty acids 
in N. commune lipid extract are unsaturated fatty acids with a potential anti-inflammatory 
property, we reasoned that fatty acids could be the major bioactive components in N. com-
mune lipid extract. As we expected, the fatty acid mixture that was constructed to reflect 
the same fatty acid composition in the N. commune lipid extract reduced the expression of 
proinflammatory mediators. The extent of the reduction, however, was less than that of 
N. commune lipid extract, indicating there are other bioactive components in the lipid ex-
tract that possess anti-inflammatory properties. 
Various bioactive compounds from blue-green algae have been reported [26]. A well-
known bioactive compound found in various blue-green algae is C-phycocyanin, a water-
soluble protein-bound pigment that accounts for more than 20% of algal dry weight [27]. 
In animal models of inflammation, such as rats and mice treated with arachidonic acid on 
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ears and carrageenan injection in paws, C-phycocyanin reduced inflammation, and this 
effect was attributed to its antioxidative and oxygen free radical scavenging properties 
[7,8]. However, as C-phycocyanin is water-soluble, other unidentified bioactive compo-
nents bearing an anti-inflammatory property are presumed to be present in N. commune 
lipid extract. It needs to be determined whether cultivated N. commune contains a high 
content of C-phycocyanin, similar to other blue-green algae. Bluegreen algae in general 
contain a high amount of carotenoids and the antioxidant properties of β-carotene could 
play a role in preventing inflammatory response. Studies have shown an inverse relation-
ship between plasma β-carotene levels and makers of inflammation, such as sialic acid and 
C-reactive protein [28,29]. In LPS-stimulated RAW 264.7 macrophages, β-carotene pre-
vented inflammatory gene expression by inhibiting NF-κB activation [30]. N. commune 
used in the present study contains approximately 70 mg/100 g (dry weight) of β-carotene, 
which is more than that of dried carrots (approximately 51 mg/100 g, US Department of 
Agriculture database). It is possible that the anti-inflammatory effect of N. commune lipid 
extract is conferred, in part, by its high β-carotene content. N. commune has been used for 
treating night blindness in Chinese medicine, and this effect could be attributed to high 
β-carotene content. Further chemical analysis for composition of N. commune lipid extract 
is necessary to identify additional bioactive compounds with an anti-inflammatory property. 
Inflammatory response to LPS is primarily mediated through the toll-like receptor 4 
(TLR-4) pathway [31,32]. Binding of LPS to TLR-4 and its coreceptors, such as cluster of 
differentiation 14 (CD14) and MD-2, triggers downstream signaling cascades, which lead 
to the activation of NF-κB. Recently, Macagno et al. [9] reported that LPS-like molecule 
extracted from a fresh-water cyanobacterium Oscillatoria planktothrix FP1 strongly inhibited 
the expression of proinflammatory cytokines in human dendritic cells as well as endotoxin 
shock in mice. In the study, authors showed that the LPS-like molecule from the cyanobac-
terium competes with LPS for binding to the TLR-4–MD2 receptor complex, possibly block-
ing LPS-induced proinflammatory signaling cascades. The nature of the repressive effect 
of N. commune lipid extract on the production of proinflammatory mediators needs to be 
further examined. NF-κB is a dimeric transcription factor that consists of p65 (RelA), c-Rel, 
RelB, p50/105, and p52/100 [33]. Activity of NF-κB can be increased by phorbor esters, pro-
inflammatory cytokines such as TNF-α and IL-1, and LPS [34]. In an unstimulated state, 
NF-κB is present in the cytoplasm bound with inhibitors of NF-κB (IκB) α/β, which masks 
the nuclear localization sequence of p65 [35]. In response to inflammatory stimulation, 
IκBα/β are phosphorylated, which are destined for ubiquitination and subsequent degra-
dation by proteasomes [36–40]. Consequently, NF-κB becomes free to translocate from the 
cytoplasm to the nucleus where it binds to the κB element of target genes participating in 
the inflammatory and immune processes [41]. As transcription of various genes that en-
code proinflammatory cytokines, chemokines, and other effectors of the innate immune 
response is increased upon the activation of NF-κB, NF-κB has been a target for the treat-
ment of inflammatory diseases [42]. Inhibition of NF-κB activation and the consequent re-
pression of various proinflammatory mediators by N. commune lipid extract in our study 
suggest its potential to be used as an anti-inflammatory agent. 
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In conclusion, we have demonstrated for the first time that a lipid extract of a blue-green 
alga, N. commune, represses the expression of several genes involved in the proinflamma-
tory response to inflammatory stimuli by the inhibition of signaling cascades leading to 
the activation of NF-κB. Because NF-κB regulates various genes involved in the inflamma-
tory responses of cells, it has been a target for the treatment of acute or chronic inflamma-
tory diseases such as sepsis, Crohn’s disease, rheumatoid arthritis, and atherosclerosis 
[43,44]. Therefore, our study provides strong scientific evidence for N. commune to be de-
veloped as a new health-enhancing nutritional food for the prevention and treatment of 
chronic inflammatory diseases and further advances our knowledge in molecular nutrition 
by elucidating pathways for the functional food at a molecular level. 
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